Lynette Sholl

68PUBLICATIONS
611CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsMicrobial geneticsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Sep 09, 2026
Phase 1 trial and biomarker analysis of Buparlisib with weekly Cisplatin and Radiotherapy in high risk locally advanced squamous cell cancer of the Head and Neck.

|Jul 14, 2026
Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer Receiving First-line Osimertinib.

|Jul 06, 2026
Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer.

|May 18, 2026
Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco.

|Dec 12, 2025
Microbiome analysis of 940 lung cancers in never-smokers reveals lack of clinically relevant associations.

John P McElderry, Tongwu Zhang, Wei Zhao

|Dec 10, 2025
Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma.

Tongwu Zhang, Wei Zhao, Christopher Wirth

Pageof 12

Frequent Collaborators

12 joint publications

Pasi A Jänne

11 joint publications

Mark M Awad

11 joint publications

Biagio Ricciuti

9 joint publications

Mizuki Nishino